Taylor Karen, Bulsara Max, Monterosso Leanne
School of Nursing and Midwifery, University of Notre Dame Australia, Perth, Western Australia, Australia.
Western Australia Cancer and Palliative Care Network, Perth, Western Australia, Australia.
Asia Pac J Oncol Nurs. 2018 Apr-Jun;5(2):165-171. doi: 10.4103/apjon.apjon_4_18.
Reliable and valid needs assessment measures are important assessment tools in cancer survivorship care. A new 30-item short-form version of the Survivor Unmet Needs Survey (SF-SUNS) was developed and validated with cancer survivors, including hematology cancer survivors; however, test-retest reliability has not been established. The objective of this study was to assess the test-retest reliability of the SF-SUNS with a cohort of lymphoma survivors ( = 40).
Test-retest reliability of the SF-SUNS was conducted at two time points: baseline (time 1) and 5 days later (time 2). Test-retest data were collected from lymphoma cancer survivors ( = 40) in a large tertiary cancer center in Western Australia. Intraclass correlation analyses compared data at time 1 (baseline) and time 2 (5 days later). Cronbach's alpha analyses were performed to assess the internal consistency at both time points.
The majority (23/30, 77%) of items achieved test-retest reliability scores 0.45-0.74 (fair to good). A high degree of overall internal consistency was demonstrated (time 1 = 0.92, time 2 = 0.95), with scores 0.65-0.94 across subscales for both time points.
Mixed test-retest reliability of the SF-SUNS was established. Our results indicate the SF-SUNS is responsive to the changing needs of lymphoma cancer survivors. Routine use of cancer survivorship specific needs-based assessments is required in oncology care today. Nurses are well placed to administer these assessments and provide tailored information and resources. Further assessment of test-retest reliability in hematology and other cancer cohorts is warranted.
可靠且有效的需求评估措施是癌症幸存者护理中的重要评估工具。一种新的30项简短版幸存者未满足需求调查问卷（SF - SUNS）已针对癌症幸存者（包括血液系统癌症幸存者）进行了开发和验证；然而，重测信度尚未确定。本研究的目的是评估SF - SUNS在一组淋巴瘤幸存者（n = 40）中的重测信度。
在两个时间点进行SF - SUNS的重测信度评估：基线（时间1）和5天后（时间2）。重测数据收集自西澳大利亚一家大型三级癌症中心的淋巴瘤癌症幸存者（n = 40）。组内相关分析比较了时间1（基线）和时间2（5天后）的数据。进行Cronbach's alpha分析以评估两个时间点的内部一致性。
大多数项目（23/30，77%）的重测信度得分在0.45 - 0.74之间（一般到良好）。两个时间点均显示出高度的整体内部一致性（时间1 = 0.92，时间2 = 0.95），各子量表得分在0.65 - 0.94之间。
确定了SF - SUNS的混合重测信度。我们的结果表明SF - SUNS能够反映淋巴瘤癌症幸存者不断变化的需求。如今肿瘤护理中需要常规使用基于癌症幸存者特定需求的评估。护士非常适合进行这些评估并提供量身定制的信息和资源。有必要进一步评估血液系统和其他癌症队列中的重测信度。
